Trump's threat of a 200% tariff on pharmaceutical products can have severe implications on Indian drugmakers, as exports to ...

Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

Asian Paints sells stake in Akzo Nobel India, GAIL extends gas agreement, SEBI proposes new guidelines, companies announce ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin's R&D teams are working on products with a near-zero global warming potential propellant . FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today ...

Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Lupin Limited (NSEI:LUPIN), with a market capitalization of ₹363.61B, rarely draw their attention ...

Lupin Ltd. agreed to buy a New Jersey-based pharmaceutical company in a $880 million deal, making its largest ever acquisition as it pushes to expand in the U.S. generic drug market.